Brief: Cytodyn Appoints Chiral Pharma To Secure Leronlimab For Local FDA Approval In Philippines
Oct 12 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN APPOINTS CHIRAL PHARMA TO SECURE LERONLIMAB FOR
LOCAL
FDA APPROVAL IN PHILIPPINES
* CYTODYN -APPOINTS CHIRAL PHARMA TO REGISTER LERONLIMAB
(PRO 140)
FOR POTENTIAL APPROVAL FROM LOCAL FDA TO TREAT PATIENTS WITH
COVID-19 IN PHILIPPINES
Source text for Eikon: ID:nGNX1WRPJg
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer